In November 2023, The European Society for Patient Adherence, Compliance, and Persistence (ESPACOMP) plans to organize its 27th annual conference, with a specific emphasis on medication adherence from drug research to patient care. The conference plans to discuss key issues in ensuring patients follow prescribed medication regimens, which are paramount to the success of treatment plans and overall healthcare outcomes.
This year's conference will bring together healthcare professionals, researchers, and policy makers to address new strategies research, and practical solutions to achieving better compliance. The agenda will cover the entire medication journey, from drug development to patient education and support, and the role of digital tools in improved compliance. ESPACOMP's focus on developing knowledge in the field is proof of its goal to drive healthier healthcare systems and patient outcomes across Europe. The conference will serve as a location for mutual exchange and the dissemination of best practice in drug adherence.
In August 2022, Athenahealth expanded their Athena One EHR and practice management suite with a new automated patient engagement function focused at boosting medication adherence. The integration of DrFirst's RxInform automated patient messaging technology enables healthcare providers to deliver personalised prescription reminders to patients directly. This function ensures that patients follow their prescribed treatment plans by sending regular reminders, which can greatly boost adherence rates.
The system also includes instructional messaging, medication warnings, and refill reminders, all of which are intended to help individuals manage their health better. Athenahealth hopes to use automation to expedite communication between healthcare practitioners and patients, minimising the chance of missing doses and improving overall treatment outcomes. This novel approach underscores the increased importance of digital technologies in improving patient involvement and medication adherence.
In January 2022, The Transplant Pharmacy, which offers specialised pharmacy services for transplant patients, was acquired by CareDxl as part of its expansion of medication adherence services. At several transplant centres across the US, The Transplant Pharmacy provides patients with personalised medication management and support. CareDxl can improve its medication adherence solutions thanks to this acquisition, especially for transplant recipients who need intricate and highly customised drug schedules.
Through better medication adherence, a lower chance of transplant rejection, and an improved patient experience overall, CareDxl hopes to enhance patient outcomes by including The Transplant Pharmacy's services into its portfolio. Additionally, by expanding CareDxl's reach to a specific patient group with particular prescription management needs, the acquisition enhances the company's standing in the healthcare industry. This action demonstrates CareDxl's dedication to developing individualised treatment plans and raising the standard of care for recipients of transplants.
According to a market report by Coherent Market Insights, the medical adherence industry globally was approximately US$ 3.5 billion in 2022 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.4% during the period between 2020 and 2025.
The medical adherence market is expanding very significantly due to a number of important factors to consider. Demand for solutions that facilitate compliance has increased with the growth of awareness regarding the value of medication compliance in enhancing patient outcomes. It is becoming easier for patients to stick to their drugs as a result of the change in patient engagement and monitoring that has been brought about by enhanced digital health technologies, such as smartphone applications and connected devices. Additionally, the market is increasing as a result of heightened prevalence of long-term disorders demanding prolonged treatment processes. Healthcare systems' focus on reducing hospital re-admissions as well as the enhancement of the efficiency of the entire care system is further promoting the adoption of adherence solutions. Furthermore, corporate social responsibility initiatives by pharmaceutical companies and healthcare organizations are playing a crucial role in driving the adoption of adherence solutions, ensuring that patients receive the necessary support for better health outcomes.
Sources:
Company: Care DXL, Athenahealth
